In cases where such genetic alterations are not detectable, a distinct DNA methylation profile characteristic of diffuse astrocytoma, MYB- or MYBL1-altered, may be sufficient to establish the diagnosis. This evidence concerns the gene MYBL1 and diffuse astrocytoma.